| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 338.43B | 316.83B | 276.08B | 252.71B | 213.00B | 204.47B |
| Gross Profit | 74.02B | 68.40B | 63.87B | 57.91B | 40.28B | 32.59B |
| EBITDA | 67.64B | 61.64B | 58.88B | 55.84B | 42.59B | 36.29B |
| Net Income | 22.53B | 19.93B | 19.83B | 18.85B | 9.71B | 4.01B |
Balance Sheet | ||||||
| Total Assets | 329.26B | 312.44B | 273.71B | 246.19B | 220.78B | 206.52B |
| Cash, Cash Equivalents and Short-Term Investments | 41.11B | 34.78B | 47.01B | 44.39B | 44.44B | 41.34B |
| Total Debt | 35.59B | 33.62B | 30.18B | 20.43B | 25.56B | 27.75B |
| Total Liabilities | 179.54B | 170.35B | 146.68B | 126.89B | 129.81B | 126.47B |
| Stockholders Equity | 148.38B | 140.68B | 125.75B | 118.12B | 89.96B | 79.08B |
Cash Flow | ||||||
| Free Cash Flow | 27.29B | 8.41B | 21.84B | 21.27B | 29.54B | 21.55B |
| Operating Cash Flow | 49.97B | 28.53B | 40.78B | 38.53B | 40.54B | 33.39B |
| Investing Cash Flow | -22.01B | -21.75B | -17.93B | -18.39B | -13.22B | -7.26B |
| Financing Cash Flow | -22.41B | -19.67B | -20.80B | -25.73B | -23.62B | -19.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $5.73B | 10.60 | 7.24% | 5.57% | 19.02% | 9.26% | |
64 Neutral | $4.65B | 9.02 | 24.66% | 7.78% | 0.59% | 8.86% | |
62 Neutral | $3.49B | 6.97 | 40.63% | ― | 6.42% | ― | |
61 Neutral | $2.86B | 19.32 | 15.34% | 1.22% | 11.79% | 2.96% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | $5.26B | -36.64 | -2.67% | 0.40% | 15.38% | -292.52% | |
52 Neutral | $4.27B | 15.83 | 8.13% | 42.91% | -25.64% | ― |